DDrare: Database of Drug Development for Rare Diseases

Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet (DrugBank: Mesalazine, Nitazoxanide)

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03441893 (ClinicalTrials.gov)	January 1, 2015	8/2/2018	Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis	Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis	Ulcerative Colitis;Ulcerative Colitis Exacerbation;Protozoan Infections;Helminth Infection	Diagnostic Test: parasitological diagnostics (coproscopy);Drug: Nitazoxanide 500Mg Oral Tablet;Drug: Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet;Drug: Mesalazine 250Mg	Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan	NULL	Active, not recruiting	18 Years	90 Years	All	300	Phase 1;Phase 2	NULL

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03441893
(ClinicalTrials.gov)

January 1, 2015

8/2/2018

Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis

Ulcerative Colitis;Ulcerative Colitis Exacerbation;Protozoan Infections;Helminth Infection

Diagnostic Test: parasitological diagnostics (coproscopy);Drug: Nitazoxanide 500Mg Oral Tablet;Drug: Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet;Drug: Mesalazine 250Mg

Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan

NULL

Active, not recruiting

18 Years

90 Years

All

300

Phase 1;Phase 2

NULL